Sightful Invest
  • Business
  • Investing
  • Politics
  • Stock
Top Posts
How to find your sample ballot for Election...
Trump stuns with call to resume nuclear tests...
Senate talks show signs of progress as government...
Johnson raises shutdown stakes on Schumer as food...
Bombshell report shows foreign charities dumped billions into...
Trump and Xi skip Taiwan talk despite years...
White House responds to reports of Trump preparing...
Former VP Kamala Harris advocates for lowering the...
Bombshell report shows foreign charities dumped billions into...
Trump designates Nigeria as ‘country of particular concern’...
  • Business
  • Investing
  • Politics
  • Stock

Sightful Invest

Investing

Russia Restricts US Uranium Exports, Retaliating to American Ban

by admin November 19, 2024
November 19, 2024
Russia Restricts US Uranium Exports, Retaliating to American Ban

The Russian government has imposed temporary restrictions on enriched uranium exports to the US.

Announced on November 15, the move follows the US’ decision toban imports of Russian uranium.

While the US legislation went into effect in August, it allows for waivers to address potential supply disruptions through 2027. The new Russian policy introduces uncertainty during this time period.

According to the US Energy Information Administration, Russia provided 27 percent of the enriched uranium used in American reactors in 2023. Globally, the country accounts for about 44 percent of enrichment capacity.

To illustrate, Urenco — a consortium-owned company operating the only US-based enrichment facility in New Mexico — supplies only about one-third of the country’s enriched uranium.

While the restrictions from Russia don’t leave the US without recourse, as utilities typically secure uranium supply years in advance, analysts are warning that continued restrictions could pose challenges from 2025 onward.

Market responses to the news were swift. Cameco (TSX:CCO,NYSE:CCJ), a leading uranium producer, emphasized in a statement to Bloomberg the need for coordinated western action to reduce reliance on Russian nuclear fuel.

Shares of uranium companies reflected the heightened supply concerns, with Cameco’s share price jumping as much as 6.5 percent on the TSX on November 15. US-based uranium firms such as Uranium Energy (NYSEAMERICAN:UEC) and Ur-Energy (TSX:URE,NYSEAMERICAN:URG) also experienced upticks that day.

Meanwhile, shares of Centrus Energy (NYSEAMERICAN:LEU), the biggest US trader of Russian enriched uranium, fell by close to 9 percent on November 15 as investors weighed the potential impacts of the restrictions.

The company said it had not received details surrounding Russia’s decree and was assessing the implications.

Centrus also noted that it has contingency plans to mitigate near-term impacts should Russia’s state-owned uranium supplier, Tenex, face challenges fulfilling existing agreements. Centrus is one company that has received a waiver from the Biden administration to continue importing Russian uranium despite the US ban.

Constellation Energy (NASDAQ:CEG) has also received a waiver, and other requests are reportedly pending.

Russia’s actions come amid broader geopolitical tensions and follow President Vladimir Putin’s earlier call for the country to consider restricting exports of uranium, titanium and nickel in response to western sanctions.

At the same time, the US government has been actively working to rebuild its uranium enrichment capabilities. A multibillion-dollar initiative to expand these operations is underway, but progress has been slow.

Overall, the US is currently looking triple its nuclear capacity by 2050, with plans to add 200 gigawatts of new nuclear energy through reactor builds, reactivations and upgrades to existing facilities.

Securities Disclosure: I, Giann Liguid, hold no direct investment interest in any company mentioned in this article.

This post appeared first on investingnews.com

previous post
Mawson Finland Limited Presents Downhole EMGeophysics: Multiple Deep Conductors Newly Identified at Rajapalot
next post
Australian Ethics Committee Approval to Expand PD-L1 Nanobody (RAD204) Phase 1 Trial in Multiple Tumor Types

You may also like

Silver Crown Royalties Purchases 1,000 Ounces of Physical...

April 9, 2025

Kobo Resources Confirms Additional High-Grade Gold Mineralization at...

July 10, 2025

Craig Hemke: Gold’s Fascinating Run, Silver and Mining...

October 8, 2024

Randy Smallwood: Silver Set for Bull Run, Gold...

June 26, 2025

Cardiex Completes Placement Ahead of CONNEQT US Launch

December 18, 2024

Anteros Returns High-Grade Lead-Zinc-Silver in Surface Samples from...

July 3, 2025

Grid Announces Appointment of New Director and Re-Engages...

August 9, 2024

Opawica Explorations Intersects Visible Gold at its Bazooka...

April 16, 2025

Uranium Energy’s Sweetwater Project Fast-Tracked Under Trump Initiative

August 7, 2025

Heritage Exercises First Option to Acquire a Majority...

January 20, 2025

Recent Posts

  • How to find your sample ballot for Election Day 2025 with races across states and cities nationwide
  • Trump stuns with call to resume nuclear tests — why now, and what it could mean
  • Senate talks show signs of progress as government shutdown grinds into 2nd month
  • Johnson raises shutdown stakes on Schumer as food stamp deadline, Obamacare cliff loom
  • Bombshell report shows foreign charities dumped billions into US political advocacy groups, ‘erode democracy’

    Sign up for our newsletter to receive the latest insights, updates, and exclusive content straight to your inbox! Whether it's industry news, expert advice, or inspiring stories, we bring you valuable information that you won't find anywhere else. Stay connected with us!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Categories

    • Business (946)
    • Investing (3,324)
    • Politics (4,065)
    • Stock (4)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: sightfulinvest.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 Sightful Invest. All Rights Reserved.